ExenatideWeight LossSafety Rating 8/10
Primary research areaType 2 diabetes
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range5-10 mcg twice daily (Byetta); 2 mg weekly (Bydureon)
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Byetta/Bydureon)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Exenatide
Mechanism of action
GLP-1 receptor agonist; slows gastric emptying and stimulates insulin secretion
Safety profile
Nausea, vomiting, pancreatitis risk · Long clinical track record; GI side effects; rare pancreatitis reports
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Exenatide below your target.
Related pages